| ²é¿´: 578 | »Ø¸´: 1 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
Mally89Ìú¸Ëľ³æ (Ö°Òµ×÷¼Ò)
|
[½»Á÷]
Ö×ÁöÃâÒß·½ÃæÁ½¾ä»°·Ò룬ÇëרҵÈËʿָ½Ì£¡
|
||
|
Active stimulation of the host¡¯s immune system holds promise for achieving durable remission of malignant disease and represents a nontoxic method of therapy if tumor-specific effector cells can be selectively targeted. However, no active-specific treatment strategy has yet found its way into the clinical armamentarium, although several promising recent reports suggest that. àÅ£¬Õâ¾ä»°»ù±¾Òâ˼Ã÷°×£¬µ«ÊǵÚÒ»¸öactive stimulationÊÇÓ¦¸Ã·Òë³ÉÓÐЧ´Ì¼¤»¹ÊÇÖ÷¶¯´Ì¼¤¡£ÇëרҵÈËÊ¿°ïæ·Òëһϣ¨×îºÃÕâÁ½¾ä»°¶¼¸øÒëһϣ©£¬Ð»Ð»£¡~ |
» ²ÂÄãϲ»¶
284Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
һ־Ըɽ¶«´óѧҩѧѧ˶Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
07»¯Ñ§280·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
298-Ò»Ö¾Ô¸Öйúũҵ´óѧ-Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
Çó²ÄÁÏ£¬»·¾³×¨Òµµ÷¼Á
ÒѾÓÐ3È˻ظ´
335Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
Ò»Ö¾Ô¸¼ª´ó»¯Ñ§322Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
»·¾³Ñ§Ë¶288Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
341Çóµ÷¼Á(Ò»Ö¾Ô¸ºþÄÏ´óѧ070300)
ÒѾÓÐ6È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
Î÷ÄϽ»Í¨´óѧҽѧԺÕÐÊÕÉúÎïҽѧ¹¤³ÌºÍ²ÄÁÏÓ뻯¹¤×¨ÒµË¶Ê¿Ñо¿Éú
+1/187
¹ú×ÔÈ»ÃæÉÏÆí¸£
+1/81
¸£½¨Å©ÁÖ´óѧ²ÄÁϹ¤³ÌѧԺ¸ß·Ö×Ó²ÄÁÏ¿ÎÌâ×éÕÐÉú
+1/79
´ºÌì¾Í¸Ã¹ä³Ô¹ä³Ô
+1/78
Î÷±±´óѧ»¯Ñ§Óë²ÄÁÏ¿ÆÑ§Ñ§Ôº²©Ê¿ÕÐÉú£¨»¹ÓÐÁ½¸öÃû¶î£¬3ÔÂ30ÈÕ½ØÖÁ£©
+1/63
Ìì½ò³Ç½¨´óѧÕÐÊÕÎïÀí¡¢»¯Ñ§»òÕßÉúÎïµ÷¼ÁÉúÒ»Ãû£¬Ç°ÍùÌì½ò´óѧÁªºÏÅàÑø
+1/33
Î÷°²Ä³´óѧÄÜÔ´»¯¹¤Ð²ÄÁÏÑз¢ÏîÄ¿×é½ÓÊÕ2026¼¶µ÷¼ÁÑо¿Éú-¼ÆËã»úÀà
+1/32
ÉϺ£½»´ó»¯Ôº¹¦ÄÜ´ó·Ö×ÓÍŶÓÕÐ2026Äê˶ʿ¡¢ÁªÅà¡¢²©Ê¿ºó
+1/31
ºþÄÏ´óѧ΢ÉúÎï½á¹¹Ó빦ÄÜʵÑéÊÒ2026Äê¼Æ»®ÕÐÊÕ²©Ê¿Ñо¿Éú
+1/13
¡¾ÉîÛÚÀí¹¤´óѧ¡¿ÔºÊ¿¹¤×÷Õ¾ÕÐÆ¸²©Ê¿ºó-µç´ß»¯ºÍÓлúµç»¯Ñ§
+1/12
±±¾©º½¿Õº½Ìì´óѧÕÐÉú΢Á÷¿ØÓëÖÇÄÜ´òÓ¡¼¼Êõ·½Ïò²©Ê¿Ñо¿Éú
+2/8
Äþ²¨¶«·½Àí¹¤´óѧÓàÅô¿ÎÌâ×é2026ÄêÉϺ£½»´óÁªÅ಩ʿÉú¡¢²©Ê¿ºó¡¢¿ÆÑÐÖúÀíÕÐÆ¸
+1/8
¡¾²©Ê¿ÕÐÉú¡¿ÉϺ£½»Í¨´óѧ³ÂÙ»èÝ¿ÎÌâ×éÕÐÊÕ2026ÄêÉêÇë-¿¼ºË²©Ê¿Éú1Ãû£¨ÄÜÔ´²ÄÁÏ·½Ïò£©
+1/7
Äϲýº½¿Õ´óѧ´úÍþÁ¦½ÌÊÚÕÐÊÕ¹â´ß»¯ºÍ¹âÈÈ´ß»¯Ñо¿·½Ïò²©Ê¿Éú
+1/6
¶àÂ×¶à´óѧ & Synetic Labs Õв©Ê¿ºó/Ñо¿Ô±
+1/6
ÉϺ£½»Í¨´óѧÕÐÆ¸£ºÐÂÐÍXÉäÏß¹ÜÉè¼Æ·ÂÕæ¼ÆË㹤³Ìʦ/²©Ê¿ºó/ÖúÀíÑо¿Ô±
+1/4
ÖйúÅ©¿ÆÔºÀ¼ÖÝÄÁÒ©ËùÊÞÒ©´´ÐÂÓëÄÍÒ©ÐÔ¿ÆÑÐÍŶӯ¸¿ÆÑÐÖúÀí£¬¼±¼±¼±£¡
+1/2
Ìì½ò´óѧÀíѧԺ·ÖÀë·ÖÎö¼°¹¦ÄܲÄÁÏÑо¿×é
+1/2
Õã½´óѧ¸ß´¿·ÖÀëÍÅ¶Ó³ÏÆ¸²©Ê¿ºó
+1/1
´óÁ¬º£Ê´óѧ´¬²°½à¾»ÄÜÔ´Ñо¿ÖÐÐÄ2026Ä격ʿÑо¿ÉúÕÐÉúÆôÊÂ
+1/1
8814402
ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)
- ·ÒëEPI: 509
- Ó¦Öú: 18 (СѧÉú)
- ¹ó±ö: 0.381
- ½ð±Ò: 12916.1
- Ìû×Ó: 4183
- ÔÚÏß: 357.8Сʱ
- ³æºÅ: 1184404
Mally89(½ð±Ò+5, ·ÒëEPI+1): ºÇºÇ£¬×ÛºÏһϻ¹²»´í~3Q~ 2011-03-19 23:08:05
|
Active stimulation of the host¡¯s immune system holds promise for achieving durable remission of malignant disease and represents a nontoxic method of therapy if tumor-specific effector cells can be selectively targeted. However, no active-specific treatment strategy has yet found its way into the clinical armamentarium, although several promising recent reports suggest that. ¶ÔÖ÷ÌåÃâÒßϵͳµÄÖ÷¶¯´Ì¼¤ÓÐÍûʹ¶ñÐÔ¼²²¡»ñµÃ»º½â£¬¿ÉÄܳÉΪһÖÖÖ×ÁöЧӦÆ÷ϸ°û°ÐÏòµÄ·Ç¶¾ÐÔÁÆ·¨¡£È»¶ø£¬¾¡¹ÜÓм¸¸ö²»´íµÄнü±¨µÀ£¬»¹Ã»ÓÐÖ÷¶¯ÌØÒìÐÔÖÎÁƲßÂÔ±»ÁÙ´²²ÉÓᣠ|
2Â¥2011-03-19 22:42:37













»Ø¸´´ËÂ¥